Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders?
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
LNTH - Lantheus Holdings, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$105.27
DETAILS
HIGH:
$120.00
LOW:
$94.00
MEDIAN:
$102.50
CONSENSUS:
$105.27
UPSIDE:
5.01%
Stock News
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Lantheus Holdings, Inc. (NasdaqGM: LNTH) to Curium US Holdings LLC. Under the terms of the proposed transaction, shareholders of Lantheus will receive $102.50 per share in cash, plus non-transferable Contingent Value Rights providing for up to $12.00 per share in potential additional cash payments,.
LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Lantheus Holdings, Inc. (NASDAQ: LNTH) to Curium US Holdings LLC for $102.50 per sha
LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Lantheus Holdings, Inc. (NASDAQ: LNTH) to Curium US Holdings LLC for $102.50 per share in cash, plus non-transferable Contingent Value Rights providing for up to $12.00 per share in potential additional cash payments, subject to achievement of specified commercial milestones for Lantheus' products through 2030.Halper Sadeh encourages Lantheus shareholders to click here to learn more about their.
US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment
The U.S. Food and Drug Administration has approved a radioactive agent from Lantheus Holdings for use in brain scans to help assess patients for Alzheimer's disease, the company said on Friday.
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer's Disease
BEDFORD, Mass., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced U.S. Food and Drug Administration (FDA) approval of TAUKLARIFY™ (florquinitau F 18 injection), also referred to as MK-6240, a radiodiagnostic agent indicated for positron emission tomography (PET) of the brain in adults with cognitive impairment who are being evaluated for Alzheimer's disease to identify patients with tau neurofibrillary tangle (NFT) pathology. TAUKLARIFY has a limitation of use. The safety and effectiveness of TAUKLARIFY have not been established for the evaluation of non-Alzheimer's disease tauopathies.
Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?
Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 7, 2026
Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (âKSFâ) are investigating the propos
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Lantheus Holdings, Inc. (NasdaqGM: LNTH) to Curium US Holdings LLC. Under the terms of the proposed transaction, shareholders of Lantheus will receive $102.50 per share in cash, plus non-transferable Contingent Value Rights providing for up to $12.00 per share in potential additional cash payments,.
Lantheus Reports Second Quarter 2026 Financial Results
Worldwide revenue of $388.2 million in the second quarter of 2026 GAAP fully diluted earnings per share of $1.11, compared to $1.12 in the second quarter of 2025 Adjusted fully diluted earnings per share of $1.55, compared to $1.57 in the second quarter of 2025 Announced on August 3, 2026 that it has entered into a definitive agreement to merge with Curium under which Curium US Holdings LLC will acquire all outstanding shares in an all-cash transaction that represents a total transaction value of up to approximately $8.0 billion BEDFORD, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today reported financial results for its second quarter ended June 30, 2026.
First Trust Advisors LP Purchases 44,713 Shares of Lantheus Holdings, Inc. $LNTH
First Trust Advisors LP boosted its position in shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) by 287.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 60,258 shares of the medical equipment provider's stock after acquiring an additional
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lantheus Holdings, Inc. (NASDAQ: LNTH)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lantheus Holdings, Inc. (NASDAQ: LNTH) PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lantheus Holdings, Inc. (NASDAQ: LNTH)
NEW YORK, Aug. 3, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Lantheus Holdings, Inc. (NASDAQ: LNTH ) related to its sale to Curium US Holdings LLC.
Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders?
Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 3, 2026
Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders?
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders
Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders PR Ne
Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, Aug. 3, 2026 /PRNewswire/ -- Ademi LLP is investigating Lantheus (NASDAQ: LNTH) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Curium. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.
Lantheus Holdings to Be Acquired for Initial $6.7 Billion
Curium said it would pay $102.50 a share in cash for Lantheus, a 2.9% premium to Friday's closing price of $99.64 and 8.5% above Lantheus's closing price of $94.47 on May 21, before Bloomberg reported that Curium was circling the company.
LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Lantheus Holdings, Inc. (NASDAQ: LNTH) to Curium US Holdings LLC for $102.50 per sha
Price Targets
B.Riley Downgrades Lantheus Holdings (LNTH) to Neutral
$105.40
(was $100.91)
Justin Walsh
·
B.Riley Financial
Lantheus downgraded to Hold from Buy at Truist
$102.50
(was $101.19)
Truist Financial
TD Cowen Downgrades Lantheus Holdings (LNTH) to Hold
$102.50
(was $101.19)
William Blair
Lantheus downgraded to Market Perform from Outperform at Leerink
$102.50
(was $101.91)
Leerink Partners
Lantheus price target raised to $125 from $115 at Truist
$125.00
(was $103.96)
Richard Newitter
·
Truist Financial
Lantheus price target raised to $120 from $115 at Mizuho
$120.00
(was $102.37)
Anthony Petrone
·
Mizuho Securities
Lantheus price target raised to $115 from $100 at Mizuho
$115.00
(was $100.06)
Mizuho Securities
Lantheus price target raised to $115 from $98 at Truist
$115.00
(was $94.27)
Truist Financial
Lantheus price target raised to $94 from $82 at Goldman Sachs
$94.00
(was $91.00)
Paul Choi
·
Goldman Sachs
Lantheus price target raised to $98 from $89 at Truist
$98.00
(was $82.68)
Richard Newitter
·
Truist Financial
Lantheus price target raised to $95 from $85 at Mizuho
$95.00
(was $80.50)
Anthony Petrone
·
Mizuho Securities
Lantheus Holdings (LNTH) PT Raised to $110 at Jefferies
$110.00
(was $80.45)
Matthew Taylor
·
Jefferies
Lantheus Holdings (LNTH) PT Raised to $89 at Truist Securities
$89.00
(was $74.91)
Richard Newitter
·
Truist Financial
Lantheus price target raised to $82 from $80 at Truist
$82.00
(was $65.35)
Truist Financial
Lantheus price target raised to $72 from $60 at Mizuho
$72.00
(was $65.17)
Mizuho Securities
Lantheus upgraded to Buy at Truist on profit re-acceleration prospects
$80.00
(was $63.09)
Richard Newitter
·
Truist Financial
Lantheus downgraded to Neutral from Buy at Goldman Sachs
$77.00
(was $51.84)
Goldman Sachs
Lantheus downgraded to Hold from Buy at Truist
$63.00
(was $56.07)
Richard Newitter
·
Truist Financial
Lantheus initiated with a Buy at Goldman Sachs
$143.00
(was $91.15)
Paul Choi
·
Goldman Sachs
Lantheus initiated with a Buy at Redburn Atlantic
$175.00
(was $106.47)
Ed Ridley-Day
·
Redburn Partners